![Sandeep Kulkarni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandeep Kulkarni
Fondateur chez
ZURA BIO LIMITED
Fortune : - $ au 31/05/2026
Profil
Sandeep C.
Kulkarni is the founder of Zura Bio Ltd., founded in 2022, serving as Chief Executive Officer & Director since 2026.
Dr. Kulkarni is the founder of Tourmaline Sub, Inc., founded in 2021, serving as Chief Executive Officer & Director since 2021.
Dr. Kulkarni is the founder of Tourmaline Bio LLC, founded in 2021, serving as Chief Executive Officer since 2021.
Dr. Kulkarni was the founder of Tourmaline Bio, Inc., founded in 2021, served as Chief Executive Officer & Director from 2021 to 2025.
The current job is Chairman at Amanat Acquisition Corp.
Former jobs include Managing Director at KVP Capital Advisors LP from 2020 to 2022, Investment Analyst at QVT Financial LP from 2013 to 2017, Consultant at The Boston Consulting Group, Inc. from 2009 to 2012, Senior Analyst at Consonance Capital Management LP, Chief Operating Officer at Immunovant, Inc. from 2018 to 2020, and Vice President-Special Projects at Roivant Sciences, Inc. Education includes a doctorate from The University of California, San Francisco and an undergraduate degree from Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Sandeep Kulkarni
| Sociétés | Poste | Début |
|---|---|---|
| ZURA BIO LIMITED | Fondateur | 01/03/2022 |
Tourmaline Bio LLC | Directeur Général | 01/09/2021 |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Fondateur | 01/09/2021 |
Anciens postes connus de Sandeep Kulkarni
| Sociétés | Poste | Fin |
|---|---|---|
KVP Capital Advisors LP
 KVP Capital Advisors LP Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 01/06/2022 |
| IMMUNOVANT, INC. | Directeur des opérations | 01/06/2020 |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial is a global multi-strategy hedge fund manager that invests in biotech and healthcare, energy and shipping, financials and structured finance, opportunistic and litigation, and technology. | Analyst-Equity | 01/08/2017 |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | 01/05/2012 |
Formation de Sandeep Kulkarni
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
QVT Financial LP
QVT Financial LP Investment ManagersFinance QVT Financial is a global multi-strategy hedge fund manager that invests in biotech and healthcare, energy and shipping, financials and structured finance, opportunistic and litigation, and technology. | Finance |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Consonance Capital Management LP
 Consonance Capital Management LP Investment ManagersFinance Consonance Capital aims to deliver exceptional, uncorrelated risk-adjusted returns through investment opportunities in the publicly traded stocks of healthcare companies. The firm seeks to meet this strategy by investing in publicly traded micro-cap, small-cap and mid-cap healthcare equities. They believe the public healthcare market lends itself to an active long/short strategy. Consonance Capital is focused on creating long and short portfolios driven by the opportunity for absolute return and alpha creation. The firm seeks to identify and analyze companies trading below their intrinsic value, which may include deep value as well as growth companies. | Finance |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KVP Capital Advisors LP
KVP Capital Advisors LP Investment ManagersFinance Provides investment advice | Finance |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
Tourmaline Bio LLC | |
Tourmaline Bio, Inc.
Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Commercial Services |
Choisissez Zonebourse 
